World News

22056 readers

131 users here now

Breaking news from around the world.

News that is American but has an international facet may also be posted here.

Guidelines for submissions:

Where possible, post the original source of information.
- If there is a paywall, you can use alternative sources or provide an archive.today, 12ft.io, etc. link in the body.
Do not editorialize titles. Preserve the original title when possible; edits for clarity are fine.
Do not post ragebait or shock stories. These will be removed.
Do not post tabloid or blogspam stories. These will be removed.
Social media should be a source of last resort.

These guidelines will be enforced on a know-it-when-I-see-it basis.

For US News, see the US News community.

This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 2 years ago

MODERATORS

HIV drug could be made for just $40 a year for every patient (www.theguardian.com)

submitted 3 months ago by alyaza@beehaw.org to c/news@beehaw.org

4 comments fedilink hide all child comments

Lenacapavir , sold as Sunlenca by US pharmaceutical giant Gilead, currently costs $42,250 for the first year. The company is being urged to make it available at a thousand times less than that price worldwide.

UNAids said it could “herald a breakthrough for HIV prevention” if the drug was available “rapidly and affordably”.

Given by injection every six months, lenacapavir can prevent infection and suppress HIV in people who are already infected.

In a trial, the drug offered 100% protection to more than 5,000 women in South Africa and Uganda, according to results announced by Gilead last month.

you are viewing a single comment's thread
view the rest of the comments

[–] theangriestbird@beehaw.org 6 points 3 months ago (3 children)

Question for my Beeple: If you could pass any law you wanted, how would you solve the problem of runaway drug costs? There is the complicating factor of "the drug companies need this money for R&D for future drugs", but clearly it's gotten out of hand.

Barring something comprehensive like Medicare For All, my thought is there should almost be a new regulatory body created for the purpose of tackling this problem. Force drug companies to provide periodic reports of how much a drug actually costs them to make, and then have a regulated maximum profit margin that drug companies are allowed to take.

[–] MonkeyTown@beehaw.org 5 points 3 months ago (1 children)

Considering how much of their research and development costs are funded by grants from governments, I’d say just get rid of private pharmaceutical companies entirely if they can’t play nice.

Give them a choice. No drug revenue at all, or any paradigm-changing drugs get their license bought out cheap.

They either go out of business entirely, and governments and academic institutions take over the work (so so much of it is paid with grants anyway, I don’t think pharma companies should keep any profits unless they fund 100% of the r&d for it, which they won’t), or they agree to sell the patents that can literally change the trajectory of a society for a fair “this is the actual amount of work we put into it plus 200% to make it worth doing.”

If they can’t be happy with that, the default option is they get to do nothing so..

But again, the profit motive of big pharma leads us to places like the opioid crisis, side effects that aren’t disclosed or even fully studied, etc. and I don’t think we should be trusting drug development to for-profit companies, at least not without much much better protections for patients and much more stringent requirements on proof of efficacy and safety.

[–] theangriestbird@beehaw.org 9 points 3 months ago

so much of it is paid with grants anyway, I don’t think pharma companies should keep any profits unless they fund 100% of the r&d for it, which they won’t

This is a strong point. If so much of this R&D is government-funded, then why tf are the drug companies allowed to profit from it? Corporate welfare is America's only real welfare problem.

load more comments (1 replies)